Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Income towards Parent Company: 2011-2024

Historic Income towards Parent Company for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $8.6 million.

  • Niagen Bioscience's Income towards Parent Company rose 143.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 1275.69%. This contributed to the annual value of $8.6 million for FY2024, which is 273.15% up from last year.
  • Niagen Bioscience's Income towards Parent Company amounted to $8.6 million in FY2024, which was up 273.15% from -$4.9 million recorded in FY2023.
  • Niagen Bioscience's 5-year Income towards Parent Company high stood at $8.6 million for FY2024, and its period low was -$27.1 million during FY2021.
  • In the last 3 years, Niagen Bioscience's Income towards Parent Company had a median value of -$4.9 million in 2023 and averaged -$5.0 million.
  • Per our database at Business Quant, Niagen Bioscience's Income towards Parent Company tumbled by 36.15% in 2021 and then soared by 273.15% in 2024.
  • Yearly analysis of 5 years shows Niagen Bioscience's Income towards Parent Company stood at -$19.9 million in 2020, then plummeted by 36.15% to -$27.1 million in 2021, then soared by 31.33% to -$18.6 million in 2022, then skyrocketed by 73.49% to -$4.9 million in 2023, then spiked by 273.15% to $8.6 million in 2024.